These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21908507)

  • 1. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Fizazi K; Greco FA; Pavlidis N; Pentheroudakis G;
    Ann Oncol; 2011 Sep; 22 Suppl 6():vi64-8. PubMed ID: 21908507
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancers of unknown primary site: ESMO clinical recommendation for diagnosis, treatment and follow-up.
    Briasoulis E; Pavlidis N; Felip E;
    Ann Oncol; 2008 May; 19 Suppl 2():ii106-7. PubMed ID: 18456742
    [No Abstract]   [Full Text] [Related]  

  • 3. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP).
    Briasoulis E; Tolis C; Bergh J; Pavlidis N;
    Ann Oncol; 2005; 16 Suppl 1():i75-6. PubMed ID: 15888766
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancers of unknown primary site: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    ; Briasoulis E; Pavlidis N
    Ann Oncol; 2007 Apr; 18 Suppl 2():ii81-2. PubMed ID: 17491060
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Pavlidis N; Briasoulis E; Pentheroudakis G;
    Ann Oncol; 2010 May; 21 Suppl 5():v228-31. PubMed ID: 20555087
    [No Abstract]   [Full Text] [Related]  

  • 6. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP).
    ESMO.
    Ann Oncol; 2001 Aug; 12(8):1057-8. PubMed ID: 11583184
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Fizazi K; Greco FA; Pavlidis N; Daugaard G; Oien K; Pentheroudakis G;
    Ann Oncol; 2015 Sep; 26 Suppl 5():v133-8. PubMed ID: 26314775
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinomas of an unknown primary site: a curable disease?
    Levy A; Massard C; Gross-Goupil M; Fizazi K
    Ann Oncol; 2008 Sep; 19(9):1657-8. PubMed ID: 18647966
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
    Krämer A; Bochtler T; Pauli C; Baciarello G; Delorme S; Hemminki K; Mileshkin L; Moch H; Oien K; Olivier T; Patrikidou A; Wasan H; Zarkavelis G; Pentheroudakis G; Fizazi K;
    Ann Oncol; 2023 Mar; 34(3):228-246. PubMed ID: 36563965
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer from an unknown primary site.
    Dowell JE
    Am J Med Sci; 2003 Jul; 326(1):35-46. PubMed ID: 12861124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and therapy of tumors from an unknown primary site].
    Novik AV; Moiseenko VM
    Vopr Onkol; 2004; 50(3):271-8. PubMed ID: 15318700
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer of unknown primary: from immunohistochemistry to gene expression profiling.
    Chiang WM; Kapadia M; Laver NV; Nystrom JS
    J Clin Oncol; 2012 Oct; 30(29):e300-2. PubMed ID: 22965966
    [No Abstract]   [Full Text] [Related]  

  • 13. SEOM clinical guideline on unknown primary cancer (2017).
    Losa F; Soler G; Casado A; Estival A; Fernández I; Giménez S; Longo F; Pazo-Cid R; Salgado J; Seguí MÁ
    Clin Transl Oncol; 2018 Jan; 20(1):89-96. PubMed ID: 29230692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma of unknown primary (CUP).
    Pavlidis N; Fizazi K
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002).
    Bugat R; Bataillard A; Lesimple T; Voigt JJ; Culine S; Lortholary A; Merrouche Y; Ganem G; Kaminsky MC; Negrier S; Perol M; Laforêt C; Bedossa P; Bertrand G; Coindre JM; Fizazi K;
    Br J Cancer; 2003 Aug; 89 Suppl 1(Suppl 1):S59-66. PubMed ID: 12915904
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis of unknown primary cancer based on molecular techniques may influence therapeutic approach and improve survival.
    Homet B; Hitt R; Ghanem I; Cortés-Funes H
    Clin Transl Oncol; 2010 Aug; 12(8):574-5. PubMed ID: 20709655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical Applications in Immunohistochemistry: Carcinomas of Unknown Primary Site.
    Kandalaft PL; Gown AM
    Arch Pathol Lab Med; 2016 Jun; 140(6):508-23. PubMed ID: 26457625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic approach to cancer of unknown primary site].
    Fernández Cotarelo MJ; Guerra Vales JM
    Rev Clin Esp; 2009; 209(7):347-51. PubMed ID: 19709540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer of unknown primary-The new ESMO guidelines].
    Bochtler T; Pouyiourou M; Krämer A
    Radiologie (Heidelb); 2023 May; 63(5):329-335. PubMed ID: 36930265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical recommendations for diagnosis, treatment and monitoring of patients with cancer of unknown primary site].
    Bišof V; Juretić A; Trivanović D; Dintinjana RD; Sarçević B; Jakić-Razumović J; Ban M; Bošković L; Mise B-; Bura M; Stančić-Rokotov D
    Lijec Vjesn; 2015; 137(3-4):65-9. PubMed ID: 26065281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.